Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?

SIMPLE SUMMARY: Over the last decade, the treatment of patients diagnosed with melanoma has transformed with the introduction of checkpoint inhibitors and targeted therapies. However, innate or acquired resistance, as well as toxicities of these treatments demands additional options for patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakish, Hanna H., Ahmed, Fasih Ali, Elshami, Mohamedraed, Loftus, Alexander W., Hoehn, Richard S., Ammori, John B., Ocuin, Lee M., Winter, Jordan M., Bordeaux, Jeremy S., Mangla, Ankit, Rothermel, Luke D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658976/
https://www.ncbi.nlm.nih.gov/pubmed/36358601
http://dx.doi.org/10.3390/cancers14215184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658976/
https://www.ncbi.nlm.nih.gov/pubmed/36358601
http://dx.doi.org/10.3390/cancers14215184

Ejemplares similares